バイオ類似品(SEB)の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Bio Similars/Subsequent Entry Biologic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C0764
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、136ページ
• 納品方法：Eメール
• 産業分類：Medical Care

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、バイオ類似品(SEB)の世界市場について調べ、まとめました。種類別セグメントは、モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、ワクチン、その他等、用途別セグメントは、等に区分しました。バイオ類似品(SEB)の世界市場概観、企業動向、企業別バイオ類似品(SEB)シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・バイオ類似品(SEB)の市場概観
・バイオ類似品(SEB)の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・バイオ類似品(SEB)の企業別販売動向、市場シェア、市場集中度、競争動向
・バイオ類似品(SEB)の世界市場規模
・バイオ類似品(SEB)の北米市場分析（アメリカ、カナダ、メキシコ等）
・バイオ類似品(SEB)のアメリカ市場規模推移
・バイオ類似品(SEB)のカナダ市場規模推移
・バイオ類似品(SEB)のメキシコ市場規模推移
・バイオ類似品(SEB)のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・バイオ類似品(SEB)のドイツ市場規模推移
・バイオ類似品(SEB)のイギリス市場規模推移
・バイオ類似品(SEB)のロシア市場規模推移
・バイオ類似品(SEB)のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・バイオ類似品(SEB)の日本市場規模推移
・バイオ類似品(SEB)の中国市場規模推移
・バイオ類似品(SEB)の韓国市場規模推移
・バイオ類似品(SEB)のインド市場規模推移
・バイオ類似品(SEB)の東南アジア市場規模推移
・バイオ類似品(SEB)の南米市場分析（ブラジル、アルゼンチン等）
・バイオ類似品(SEB)の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・バイオ類似品(SEB)の種類別分析/販売量、売上、市場シェア（モノクローナル抗体、インターフェロン、エリスロポエチン、インスリン、ワクチン、その他）
・バイオ類似品(SEB)の用途別分析/市場規模（）
・バイオ類似品(SEB)の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・バイオ類似品(SEB)の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Bio Similars/Subsequent Entry Biologic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bio Similars/Subsequent Entry Biologic.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Bio Similars/Subsequent Entry Biologic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bio Similars/Subsequent Entry Biologic market by product type and applications/end industries.

Market Segment by Companies, this report covers
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen idec
Genentech (Roche)
Pfizer
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy’s Laboratories
Stada Arzneimittel AG
AbbVie
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3sbio
Biotech
Gelgen
Innovent
Dong Bao
Ganlee

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other

Market Segment by Applications, can be divided into
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

レポート目次

Table of Contents

1 Bio Similars/Subsequent Entry Biologic Market Overview
1.1 Product Overview and Scope of Bio Similars/Subsequent Entry Biologic
1.2 Classification of Bio Similars/Subsequent Entry Biologic by Types
1.2.1 Global Bio Similars/Subsequent Entry Biologic Revenue Comparison by Types (2019-2024)
1.2.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Types in 2018
1.2.3 Monoclonal Antibodies
1.2.4 Interferon
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Other
1.3 Global Bio Similars/Subsequent Entry Biologic Market by Application
1.3.1 Global Bio Similars/Subsequent Entry Biologic Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Global Bio Similars/Subsequent Entry Biologic Market by Regions
1.4.1 Global Bio Similars/Subsequent Entry Biologic Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bio Similars/Subsequent Entry Biologic Status and Prospect (2014-2024)
1.5 Global Market Size of Bio Similars/Subsequent Entry Biologic (2014-2024)
2 Manufacturers Profiles
2.1 Sun Pharma
2.1.1 Business Overview
2.1.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.2 Synthon Pharmaceuticals
2.2.1 Business Overview
2.2.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.4 LG Life Sciences
2.4.1 Business Overview
2.4.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.5 Celltrion Biocon
2.5.1 Business Overview
2.5.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.6 Hospira
2.6.1 Business Overview
2.6.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.7 Merck
2.7.1 Business Overview
2.7.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biogen idec
2.8.1 Business Overview
2.8.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.9 Genentech (Roche)
2.9.1 Business Overview
2.9.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.10 Pfizer
2.10.1 Business Overview
2.10.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.11 Celltrion
2.11.1 Business Overview
2.11.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.12 Biocon
2.12.1 Business Overview
2.12.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.13 Amgen
2.13.1 Business Overview
2.13.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.14 Samsung Biologics
2.14.1 Business Overview
2.14.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.15 Mylan
2.15.1 Business Overview
2.15.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.16 Dr. Reddy’s Laboratories
2.16.1 Business Overview
2.16.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Dr. Reddy’s Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.17 Stada Arzneimittel AG
2.17.1 Business Overview
2.17.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.18 AbbVie
2.18.1 Business Overview
2.18.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.19 Sanofi-Aventis
2.19.1 Business Overview
2.19.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.20 Johnson & Johnson
2.20.1 Business Overview
2.20.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.21 Novo Nordisk
2.21.1 Business Overview
2.2.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.22 Eli Lilly
2.22.1 Business Overview
2.22.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.23 Novartis
2.23.1 Business Overview
2.23.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.24 3sbio
2.24.1 Business Overview
2.24.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.25 Biotech
2.25.1 Business Overview
2.25.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.26 Gelgen
2.26.1 Business Overview
2.26.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.27 Innovent
2.27.1 Business Overview
2.27.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.28 Dong Bao
2.28.1 Business Overview
2.28.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
2.29 Ganlee
2.29.1 Business Overview
2.29.2 Bio Similars/Subsequent Entry Biologic Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
3 Global Bio Similars/Subsequent Entry Biologic Market Competition, by Players
3.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Bio Similars/Subsequent Entry Biologic Players Market Share
3.2.2 Top 10 Bio Similars/Subsequent Entry Biologic Players Market Share
3.3 Market Competition Trend
4 Global Bio Similars/Subsequent Entry Biologic Market Size by Regions
4.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Regions
4.2 North America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
4.3 Europe Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
4.5 South America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
5 North America Bio Similars/Subsequent Entry Biologic Revenue by Countries
5.1 North America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
5.2 USA Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
5.3 Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
5.4 Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
6 Europe Bio Similars/Subsequent Entry Biologic Revenue by Countries
6.1 Europe Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
6.2 Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
6.3 UK Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
6.4 France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
6.5 Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
6.6 Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Countries
7.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
7.2 China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
7.3 Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
7.4 Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
7.5 India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
8 South America Bio Similars/Subsequent Entry Biologic Revenue by Countries
8.1 South America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
8.2 Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
8.3 Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
8.4 Colombia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Bio Similars/Subsequent Entry Biologic by Countries
9.1 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
9.2 Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
9.3 UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
9.4 Egypt Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
9.5 Nigeria Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
9.6 South Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
10 Global Bio Similars/Subsequent Entry Biologic Market Segment by Type
10.1 Global Bio Similars/Subsequent Entry Biologic Revenue and Market Share by Type (2014-2019)
10.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Type (2019-2024)
10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
10.4 Interferon Revenue Growth Rate (2014-2024)
10.5 Erythropoietin Revenue Growth Rate (2014-2024)
10.6 Insulin Revenue Growth Rate (2014-2024)
10.7 Vaccines Revenue Growth Rate (2014-2024)
10.8 Other Revenue Growth Rate (2014-2024)
11 Global Bio Similars/Subsequent Entry Biologic Market Segment by Application
11.1 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application (2014-2019)
11.2 Bio Similars/Subsequent Entry Biologic Market Forecast by Application (2019-2024)
11.3 Tumor Revenue Growth (2014-2019)
11.4 Diabetes Revenue Growth (2014-2019)
11.5 Cardiovascular Revenue Growth (2014-2019)
11.6 Hemophilia Revenue Growth (2014-2019)
11.7 Other Revenue Growth (2014-2019)
12 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)
12.1 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast (2019-2024)
12.2 Global Bio Similars/Subsequent Entry Biologic Market Forecast by Regions (2019-2024)
12.3 North America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
12.4 Europe Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
12.6 South America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Bio Similars/Subsequent Entry Biologic Picture
Table Product Specifications of Bio Similars/Subsequent Entry Biologic
Table Global Bio Similars/Subsequent Entry Biologic and Revenue (Million USD) Market Split by Product Type
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Types in 2018
Figure Monoclonal Antibodies Picture
Figure Interferon Picture
Figure Erythropoietin Picture
Figure Insulin Picture
Figure Vaccines Picture
Figure Other Picture
Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Application (2014-2024)
Figure Bio Similars/Subsequent Entry Biologic Revenue Market Share by Applications in 2018
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Table Global Market Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (2014-2024)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Bio Similars/Subsequent Entry Biologic Type and Applications
Table Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Synthon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Type and Applications
Table Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Type and Applications
Table Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Type and Applications
Table LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Celltrion Biocon Basic Information, Manufacturing Base and Competitors
Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Type and Applications
Table Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Hospira Basic Information, Manufacturing Base and Competitors
Table Hospira Bio Similars/Subsequent Entry Biologic Type and Applications
Table Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Bio Similars/Subsequent Entry Biologic Type and Applications
Table Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen idec Basic Information, Manufacturing Base and Competitors
Table Biogen idec Bio Similars/Subsequent Entry Biologic Type and Applications
Table Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Type and Applications
Table Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Bio Similars/Subsequent Entry Biologic Type and Applications
Table Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Celltrion Basic Information, Manufacturing Base and Competitors
Table Celltrion Bio Similars/Subsequent Entry Biologic Type and Applications
Table Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Bio Similars/Subsequent Entry Biologic Type and Applications
Table Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Bio Similars/Subsequent Entry Biologic Type and Applications
Table Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Type and Applications
Table Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Bio Similars/Subsequent Entry Biologic Type and Applications
Table Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Type and Applications
Table Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Stada Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Type and Applications
Table Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Bio Similars/Subsequent Entry Biologic Type and Applications
Table AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Type and Applications
Table Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Type and Applications
Table Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Type and Applications
Table Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Bio Similars/Subsequent Entry Biologic Type and Applications
Table Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Bio Similars/Subsequent Entry Biologic Type and Applications
Table Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table 3sbio Basic Information, Manufacturing Base and Competitors
Table 3sbio Bio Similars/Subsequent Entry Biologic Type and Applications
Table 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Biotech Basic Information, Manufacturing Base and Competitors
Table Biotech Bio Similars/Subsequent Entry Biologic Type and Applications
Table Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Gelgen Basic Information, Manufacturing Base and Competitors
Table Gelgen Bio Similars/Subsequent Entry Biologic Type and Applications
Table Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Innovent Basic Information, Manufacturing Base and Competitors
Table Innovent Bio Similars/Subsequent Entry Biologic Type and Applications
Table Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Dong Bao Basic Information, Manufacturing Base and Competitors
Table Dong Bao Bio Similars/Subsequent Entry Biologic Type and Applications
Table Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Ganlee Basic Information, Manufacturing Base and Competitors
Table Ganlee Bio Similars/Subsequent Entry Biologic Type and Applications
Table Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2017-2018)
Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Players (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2017
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2018
Figure Global Top 5 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2018
Figure Global Top 10 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2018
Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Regions (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions in 2018
Figure North America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Europe Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure South America Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Table North America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
Table North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018
Figure USA Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Canada Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Mexico Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Table Europe Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)
Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018
Figure Germany Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure UK Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure France Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Russia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Italy Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018
Figure China Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Japan Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Korea Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure India Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Table South America Bio Similars/Subsequent Entry Biologic Revenue by Countries (2014-2019)
Table South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018
Figure Brazil Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Argentina Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Colombia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries in 2018
Figure Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure UAE Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Egypt Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure Nigeria Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Figure South Africa Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) by Type (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type in 2018
Table Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Type (2019-2024)
Figure Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Type (2019-2024)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2014-2019)
Figure Global Interferon Revenue Growth Rate (2014-2019)
Figure Global Erythropoietin Revenue Growth Rate (2014-2019)
Figure Global Insulin Revenue Growth Rate (2014-2019)
Figure Global Vaccines Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue by Application (2014-2019)
Table Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application in 2018
Table Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Application (2019-2024)
Figure Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Application (2019-2024)
Figure Global Tumor Revenue Growth Rate (2014-2019)
Figure Global Diabetes Revenue Growth Rate (2014-2019)
Figure Global Cardiovascular Revenue Growth Rate (2014-2019)
Figure Global Hemophilia Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Bio Similars/Subsequent Entry Biologic Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Bio Similars/Subsequent Entry Biologic Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
Figure Europe Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
Figure South America Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Bio Similars/Subsequent Entry Biologic Revenue Market Forecast (2019-2024)

Global Polyhydroxybutyrate (PHB) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C4567 2019年8月 121Pages
本調査レポートは、ポリヒドロキシ酪酸(PHB)の世界市場について調べ、まとめました。種類別セグメントは、ラルストニア·ユートロフィクス等、用途別セグメントは、製薬、食品、農業、その他等に区分しました。ポリヒドロキシ酪酸(PHB)の世界市場概観、企業動向、企業別ポリヒドロキシ酪酸(PHB)シェア、市場...

神経修復及び再生生物製剤市場：世界及び中国市場分析・予測（～2024年）

Nerve Repair and Re-generation Biologic Products Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9J06163 2019年7月 138Pages
世界及び中国における神経修復及び再生生物製剤市場について調査・分析したレポートで、神経修復及び再生生物製剤の世界市場動向、市場規模、主要企業情報などが含まれています。神経修復及び再生生物製剤の種類別には、神経導管、神経ラップ、神経移植、その他に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中...

鉄筋（RB）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Rebar(RB) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4872 2019年7月 137Pages
本調査レポートは、鉄筋（RB）の世界市場について調べ、まとめました。種類別セグメントは、60、 75、その他等、用途別セグメントは、等に区分しました。鉄筋（RB）の世界市場概観、企業動向、企業別鉄筋（RB）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ...

1,3-ブタジエン（BD）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global 1,3-Butadiene (BD) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6521 2019年7月 139Pages
本調査レポートは、1,3-ブタジエン（BD）の世界市場について調べ、まとめました。種類別セグメントは、DMF法、ACN法、NMP法等、用途別セグメントは、等に区分しました。1,3-ブタジエン（BD）の世界市場概観、企業動向、企業別1,3-ブタジエン（BD）シェア、市場規模推移、市場規模予測（2019...

CMTS（QAM）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global CMTS (QAM) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1296 2019年8月 115Pages
本調査レポートは、CMTS（QAM）の世界市場について調べ、まとめました。種類別セグメントは、統合CMTS（I-CMTS）、モジュラーCMTS（M-CMTS）等、用途別セグメントは、化粧品、ヘルスケア、自動車、その他等に区分しました。CMTS（QAM）の世界市場概観、企業動向、企業別CMTS（QAM...

小型モジュラーリアクター（SMR）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Small Modular Reactors (SMRs) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5250 2019年7月 139Pages
本調査レポートは、小型モジュラーリアクター（SMR）の世界市場について調べ、まとめました。種類別セグメントは、熱中性子炉、高速中性子炉等、用途別セグメントは、等に区分しました。小型モジュラーリアクター（SMR）の世界市場概観、企業動向、企業別小型モジュラーリアクター（SMR）シェア、市場規模推移、市...

契約バイオ製造機関（CMO）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Contract Bio-manufacturing Organization(CMO) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1471 2019年7月 139Pages
本調査レポートは、契約バイオ製造機関（CMO）の世界市場について調べ、まとめました。種類別セグメントは、成長因子、インターフェロン、モノクローナル抗体、組み換えホルモン、ワクチン、インスリン、その他等、用途別セグメントは、等に区分しました。契約バイオ製造機関（CMO）の世界市場概観、企業動向、企業別...

電解ブリキ（ETP）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Electrolytic Tinplate (ETP) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C2025 2019年7月 137Pages
本調査レポートは、電解ブリキ（ETP）の世界市場について調べ、まとめました。種類別セグメントは、プライムグレード電解ブリキ、二級グレードブリキ、その他等、用途別セグメントは、等に区分しました。電解ブリキ（ETP）の世界市場概観、企業動向、企業別電解ブリキ（ETP）シェア、市場規模推移、市場規模予測（...

バーチャルプライベートサーバ（VPS）の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Virtual Private Servers (VPS) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C6235 2019年7月 136Pages
本調査レポートは、バーチャルプライベートサーバ（VPS）の世界市場について調べ、まとめました。種類別セグメントは、Windowsオペレーティングシステム、Linuxオペレーティングシステム等、用途別セグメントは、等に区分しました。バーチャルプライベートサーバ（VPS）の世界市場概観、企業動向、企業別...

傾角計（傾斜計）の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Inclinometers (Tiltmeters) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C2956 2019年8月 139Pages
本調査レポートは、傾角計（傾斜計）の世界市場について調べ、まとめました。種類別セグメントは、機械式傾斜計、デジタル傾斜計、電子傾斜計等、用途別セグメントは、土木、電気、掘削、その他等に区分しました。傾角計（傾斜計）の世界市場概観、企業動向、企業別傾角計（傾斜計）シェア、市場規模推移、市場規模予測（2...

神経修復及び再生生物製剤市場：世界及び中国市場分析・予測（～2024年） Nerve Repair and Re-generation Biologic Products Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Nerve Repair and Re-generation Biologic Products industry with a focus on the Chinese market. The report provides key statistics …
世界の血漿タンパク質システム市場：市場規模・現状・予測 Plasma protein system is a unique and biologic pathway that are either injected or infused to treat a life-threatening chronic and generic disease including pulmonary disorder, neurologic disorder, bleeding disorder, immune deficiencies, liver cirrhosis, trauma and others.In 2018, the global Plasma …
世界のヒトB型肝炎免疫グロブリン市場2019 The global Human Hepatitis B Immunoglobulin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Human Hepatitis B Immunoglobulin market status and forecast, categorizes the global Human Hepatiti…
世界の静脈内免疫グロブリン療法市場：市場規模・現状・予測 Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.In 2018, the global Intravenous Immune Globulin Therapies market siz…
女性用骨盤インプラントの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Female Pelvic Implants is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Female Pelvic Implants in …